Vitamin D improves vascular function and decreases monoamine oxidase A expression in experimental diabetes

[1]  S. Wimalawansa.  Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  D. Mochly‐Rosen,et al.  Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes , 2018, Cell Death & Differentiation.

[3]  Prasenjit Manna,et al.  1,25(OH)2-vitamin D3 upregulates glucose uptake mediated by SIRT1/IRS1/GLUT4 signaling cascade in C2C12 myotubes , 2018, Molecular and Cellular Biochemistry.

[4]  I. Romoşan,et al.  Vitamin D Status, Disease Activity, and Endothelial Dysfunction in Early Rheumatoid Arthritis Patients , 2017, Disease markers.

[5]  P. Lips,et al.  Vitamin D and type 2 diabetes , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  D. Angoulvant,et al.  The effect of purinergic signaling via the P2Y11 receptor on vascular function in a rat model of acute inflammation , 2017, Molecular and Cellular Biochemistry.

[7]  D. Angoulvant,et al.  The effect of purinergic signaling via the P2Y11 receptor on vascular function in a rat model of acute inflammation , 2017, Molecular and Cellular Biochemistry.

[8]  M. Saif-Elnasr,et al.  Role of Vitamin D on glycemic control and oxidative stress in type 2 diabetes mellitus , 2017, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[9]  C. Nediani,et al.  Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target , 2016, Oxidative medicine and cellular longevity.

[10]  F. Peng,et al.  Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress: An in vivo and in vitro study. , 2016, Atherosclerosis.

[11]  C. Borza,et al.  Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts , 2016, Oxidative medicine and cellular longevity.

[12]  D. Muntean,et al.  Monoamine oxidase inhibition improves vascular function in mammary arteries from nondiabetic and diabetic patients with coronary heart disease. , 2016, Canadian journal of physiology and pharmacology.

[13]  F. Orio,et al.  Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? , 2016, Endocrine.

[14]  S. Makariou,et al.  The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[15]  M. Wainstein,et al.  Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. , 2015, World journal of diabetes.

[16]  Gülis Kavadar,et al.  The relationship between vitamin D status, physical activity and insulin resistance in overweight and obese subjects. , 2015, Bosnian journal of basic medical sciences.

[17]  B. Timar,et al.  Vitamin D Deficiency—Prognostic Marker or Mortality Risk Factor in End Stage Renal Disease Patients with Diabetes Mellitus Treated with Hemodialysis—A Prospective Multicenter Study , 2015, PloS one.

[18]  L. Tarnow,et al.  Vitamin D, carotid intima–media thickness and bone structure in patients with type 2 diabetes , 2015, Endocrine connections.

[19]  Hongying Dai,et al.  Vitamin D, Low-Grade Inflammation and Cardiovascular Risk in Young Children: A Pilot Study , 2015, Pediatric Cardiology.

[20]  Francisco das Chagas Monteiro Júnior,et al.  Is Vitamin D Deficiency a New Risk Factor for Cardiovascular Disease? , 2015, The open cardiovascular medicine journal.

[21]  A. Varró,et al.  Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes. , 2015, Canadian journal of physiology and pharmacology.

[22]  C. Agostoni,et al.  Vitamin D insufficiency in obese children and relation with lipid profile , 2015, International journal of food sciences and nutrition.

[23]  M. Dănilă,et al.  Reduction of Rage Expression by Vitamin D in Isolated Diabetic Rat Aortas , 2015 .

[24]  C. Gleissner.  The vulnerable vessel , 2015, Hämostaseologie.

[25]  J. DiNicolantonio,et al.  Vitamin D and atherosclerosis , 2014, Current opinion in cardiology.

[26]  K. Badenhoop,et al.  Vitamin D Promotes Vascular Regeneration , 2014, Circulation.

[27]  M. Hellmich,et al.  A score to quantify coronary plaque vulnerability in high-risk patients with type 2 diabetes: an optical coherence tomography study , 2014, Cardiovascular Diabetology.

[28]  N. Kaludercic,et al.  Monoamine oxidases as sources of oxidants in the heart. , 2014, Journal of molecular and cellular cardiology.

[29]  D. Seals,et al.  You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging. , 2014, Physiology.

[30]  N. Stern,et al.  New vitamin D less-calcemic analog affect human bone cell line and cultured vascular smooth muscle cells similar to other less-calcemic analogs , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  D. Kass,et al.  Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. , 2014, Antioxidants & redox signaling.

[32]  T. Ferguson,et al.  Monoamine Oxidase is a Major Determinant of Redox Balance in Human Atrial Myocardium and is Associated With Postoperative Atrial Fibrillation , 2014, Journal of the American Heart Association.

[33]  T. Saikawa,et al.  Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[34]  E. Renard,et al.  Short‐term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47phox subunit in monocytes from type 2 diabetes patients , 2013, Fundamental & clinical pharmacology.

[35]  C. Sena,et al.  Endothelial dysfunction - a major mediator of diabetic vascular disease. , 2013, Biochimica et biophysica acta.

[36]  D. Mousseau,et al.  An update on amine oxidase inhibitors: Multifaceted drugs , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[37]  R. Brandes,et al.  Monoamine Oxidases Are Mediators of Endothelial Dysfunction in the Mouse Aorta , 2013, Hypertension.

[38]  J. Manson,et al.  Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes , 2013, Diabetes Care.

[39]  R. Kitazawa,et al.  Anti-Oxidative Effect of Vitamin D Analog on Incipient Vascular Lesion in Non-Obese Type 2 Diabetic Rats , 2013, American Journal of Nephrology.

[40]  Keith C. Norris,et al.  1,25(OH)2vitamin D3 enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C2C12 skeletal muscle cells , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  河野 圭志.  Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats , 2013 .

[42]  O. Fira-Mladinescu,et al.  Monoamine oxidase--a inhibition reverses endothelial dysfunction in hypertensive rat aortic rings. , 2013, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[43]  Nicolas Chenouard,et al.  Icy: an open bioimage informatics platform for extended reproducible research , 2012, Nature Methods.

[44]  M. Holick.  Vitamin D: evolutionary, physiological and health perspectives. , 2011, Current drug targets.

[45]  K. Hirata,et al.  Oral Administration of an Active Form of Vitamin D3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[46]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[47]  P. Knekt,et al.  Serum vitamin D and the risk of Parkinson disease. , 2010, Archives of neurology.

[48]  R. Brandes,et al.  Differential vascular functions of Nox family NADPH oxidases , 2008, Current opinion in lipidology.

[49]  A. Mackay-Sim,et al.  Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice , 2008, Behavioural Brain Research.

[50]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[51]  W. Cass,et al.  Calcitriol Protects against the Dopamine‐ and Serotonin‐Depleting Effects of Neurotoxic Doses of Methamphetamine , 2006, Annals of the New York Academy of Sciences.

[52]  Keith F. Tipton,et al.  The therapeutic potential of monoamine oxidase inhibitors , 2006, Nature Reviews Neuroscience.

[53]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[54]  E. Masini,et al.  Oxidative Stress by Monoamine Oxidase Mediates Receptor-Independent Cardiomyocyte Apoptosis by Serotonin and Postischemic Myocardial Injury , 2005, Circulation.